rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Aurobindo Pharma Ltd. - Research Center
524804 AUROPHARMA Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Profit loss account
(Rs crore)
Mar ' 20 Mar ' 19 Mar ' 18 Mar ' 17 Mar ' 16
Income
Operating income 13,266.48 12,257.89 10,269.90 9,607.05 9,166.18
Expenses
Material consumed 6,692.42 6,362.95 4,704.45 4,786.22 4,428.43
Manufacturing expenses 520.30 505.96 433.02 405.09 393.06
Personnel expenses 1,561.47 1,362.77 1,131.64 927.30 807.05
Selling expenses - - - - -
Adminstrative expenses 1,806.54 1,616.92 1,330.78 1,114.49 1,085.85
Expenses capitalised - - - - -
Cost of sales 10,580.73 9,848.60 7,599.89 7,233.10 6,714.39
Operating profit 2,685.75 2,409.29 2,670.01 2,373.95 2,451.79
Other recurring income 403.37 199.22 80.65 135.95 188.36
Adjusted PBDIT 3,089.12 2,608.51 2,750.66 2,509.90 2,640.15
Financial expenses 240.94 230.86 52.89 45.16 229.31
Depreciation 470.48 413.03 354.83 286.17 263.00
Other write offs - - - - -
Adjusted PBT 2,377.70 1,964.62 2,342.94 2,178.57 2,147.84
Tax charges 504.96 434.89 530.17 471.81 521.14
Adjusted PAT 1,872.74 1,529.73 1,812.77 1,706.76 1,626.70
Non recurring items - - - - -
Other non cash adjustments - - - - -
Reported net profit 1,872.74 1,529.73 1,812.77 1,706.76 1,626.70
Earnigs before appropriation 12,032.87 10,320.47 9,055.18 7,379.75 5,834.72
Equity dividend 166.12 132.62 174.98 90.88 107.01
Preference dividend - - - - -
Dividend tax 9.66 13.86 44.73 23.23 27.36
Retained earnings 11,857.09 10,173.99 8,835.47 7,265.64 5,700.35

Mutual Fund Selector

Find the fund that is right for you
Close
Add Aurobindo Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Aurobindo Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close